Open Access 01-12-2015 | Research highlight
Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer
Published in: Journal of Hematology & Oncology | Issue 1/2015
Login to get accessOpen Access 01-12-2015 | Research highlight
Published in: Journal of Hematology & Oncology | Issue 1/2015
Login to get access